Rhythm Pharmaceuticals Inc (RYTM)
57.87
-2.14
(-3.57%)
USD |
NASDAQ |
Jan 08, 16:00
57.75
-0.12
(-0.21%)
After-Hours: 20:00
Rhythm Pharmaceuticals SG&A Expense (Quarterly): 35.38M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| MannKind Corp | 23.92M |
| TG Therapeutics Inc | 41.97M |
| Voyager Therapeutics Inc | 8.168M |
| Krystal Biotech Inc | 28.71M |
| NovaBay Pharmaceuticals Inc | 2.65M |